{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T08:12:54Z","timestamp":1765267974020},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.radonc.2008.09.018","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T04:08:42Z","timestamp":1225339722000},"page":"172-176","source":"Crossref","is-referenced-by-count":101,"title":["Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer"],"prefix":"10.1016","volume":"90","author":[{"given":"David I.","family":"Pryor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro V.","family":"Porceddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bryan H.","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Guminski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien B.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine","family":"Shepherdson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2008.09.018_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2008.09.018_bib2","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2006.08.8005","article-title":"Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab","volume":"25","author":"Curran","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMc071075","article-title":"Homey B: severe cutaneous reaction during radiation therapy with concurrent cetuximab","volume":"357","author":"Budach","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2008.09.018_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2007.04.034","article-title":"Acneiform rash secondary to cetuximab plus head and neck radiotherapy","volume":"85","author":"Mydin","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1748-717X-3-5","article-title":"Severe skin reaction secondary to concomitant radiotherapy plus cetuximab","volume":"3","author":"Berger","year":"2008","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00066-008-1829-z","article-title":"Development and management of severe cutaneous side effects in head-and-neck cancer patients during concurrent radiotherapy and cetuximab","volume":"184","author":"Bolke","year":"2008","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2008.09.018_bib7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clon.2007.09.003","article-title":"Cetuximab is effective, but more toxic than reported in the Bonner trial","volume":"20","author":"Lord","year":"2008","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.radonc.2008.09.018_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A radiation therapy oncology group (RTOG) phase iii randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2008.09.018_bib9","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2006.08.057","article-title":"Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial","volume":"24","author":"Bourhis","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib10","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2008.09.018_bib11","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib12","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogene repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/annonc\/mdm400","article-title":"Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck","volume":"19","author":"Bernier","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib14","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/annonc\/mdi279","article-title":"Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors","volume":"16","author":"Segaert","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2008.09.018_bib15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc1970","article-title":"Mechanisms of cutaneous toxicities to EGFR inhibitors","volume":"6","author":"Lacouture","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.radonc.2008.09.018_bib16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ejca.2006.11.016","article-title":"Classification and management of skin, hair, nail and mucosal side-effects of epidermal growth factor receptor (EGFR) inhibitors","volume":"43","author":"Galimont-Collen","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2008.09.018_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaad.2006.09.005","article-title":"Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management","volume":"56","author":"Hu","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.radonc.2008.09.018_bib18","first-page":"97939","article-title":"EGFR activation and ultraviolet light-induced skin carcinogenesis","author":"El-Abaseri","year":"2007","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.radonc.2008.09.018_bib19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/carcin\/bgi220","article-title":"Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor","volume":"27","author":"El-Abaseri","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.radonc.2008.09.018_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2307\/3578641","article-title":"Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation","volume":"136","author":"Peter","year":"1993","journal-title":"Radiat Res"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814008005185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814008005185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T15:22:36Z","timestamp":1545664956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814008005185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0167814008005185"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2008.09.018","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}